LUCAS RAMOS DE PRETTO

Projetos de Pesquisa
Unidades Organizacionais
Cargo

Resultados de Busca

Agora exibindo 1 - 4 de 4
  • Artigo IPEN-doc 29934
    Noninvasive red Laser intervention before radiotherapy of triple-negative breast cancer in a murine model
    2023 - SILVA, CAMILA R.; PEREIRA, SAULO T.; SILVA, DANIELA F.T.; PRETTO, LUCAS R. de; FREITAS, ANDERSON Z.; ZEITUNI, CARLOS A.; ROSTELATO, MARIA E.C.M.; RIBEIRO, MARTHA S.
    In proton beam treatments, the superposition of several weighted Bragg curves with different incident energies is required to homogeneously irradiate a large tumor volume, creating a spread-out Bragg peak (SOBP). This paper confirms on the suitability of two different methods to create SOBPs – Bortfeld/Jette's and MCMC (Monte Carlo calculations and Matrix Computations), using Monte Carlo simulations performed with TOPAS and MCNP6.1. To generate the SOBPs, algorithms were developed for implementation of the two methods, which enabled to find the weights for thirty variations of SOBPs, categorized according to their width and maximum depths. The MCMC method used weight optimization in designing SOBPs to avoid negative values. In contrast, the Bortfeld/Jette's method yielded the SOBPs according to the variation of a power-law parameter ( ) introduced by the range-energy relationship. Optimal values of , from MCNP and TOPAS, were selected in order to retrieve SOBPs with the best smoothness and then related to those obtained from the literature. In comparing both methods and codes, dose homogeneity parameters ( ) were used to examine the SOBP flatness and gamma analyses were employed to assess the dose deposition along its full extension. The results showed that the SOBPs designed using the MCMC method had better values and computational performance for both codes when compared to the Bortfeld/Jette's method. The gamma analyses highlighted significant differences between the entrance doses comparing the two different methods, for SOBPs with intermediate and high depths and small width. This evaluation was not possible with the values alone, which stresses the relevance of a broad analysis to avoid unintended doses in healthy tissues.
  • Resumo IPEN-doc 29546
    Photobiomodulation therapy as a radiosensitizer for triple-negative breast cancer
    2022 - SILVA, CAMILA R.; PEREIRA, SAULO de T.; PRETTO, LUCAS R. de; FREITAS, ANDERSON Z. de; RIBEIRO, MARTHA S.
    INTRODUCTION: Radiotherapy (RT) is an essential cancer treatment and is estimated that approximately 52% of oncological patients will be submitted to this technique once. However, some tumors, such as triple-negative breast cancer (TNBC), present radioresistance, demanding high doses of ionizing radiation (IR) and a prolonged period of treatment, which contributes to secondary malignancies due to deposition of dose in organs at risk and several side effects. Moreover, this subtype of cancer shows a high incidence of metastasis and decreases the survival expectancy of the patient. Thus, the search for new agents that can act as a radiosensitizer to improve the RT effects has been growing. Conversely, photobiomodulation therapy (PBM), which is a promising therapy with increasing adhesion in clinical practice, has been used to mitigate the adverse effects of RT. Indeed, recent studies have associated PBM with RT to combat cancer. OBJECTIVES: In this study, we used TNBC-bearing mice as a radioresistant cancer model to verify if PBM could act as a radiosensitizer MATERIALS AND METHODS: PBM was applied in two different protocols before the RT with a high dose (60 Gy fractioned in 4 sessions). We evaluated the tumor volume progression, animal clinical evolution, lung metastases by optical coherence tomography, and animal survival DISCUSSION AND RESULTS: Our data indicate that PBM before each RT session arrested the tumor volume, improved the clinical signals of the animals, reduced the nodules in the lung, and extended animal survival. CONCLUSION: In the light of the knowledge gained, our data indicate that PBM could act as a radiosensitizer.
  • Artigo IPEN-doc 22984
    Optical Coherence Tomography for blood glucose monitoring through signal attenuation
    2016 - PRETTO, LUCAS R. de; YOSHIMURA, TANIA M.; RIBEIRO, MARTHA S.; FREITAS, ANDERSON Z. de
    Development of non-invasive techniques for glucose monitoring is crucial to improve glucose control and treatment adherence in patients with diabetes. Hereafter, Optical Coherence Tomography (OCT) may offer a good alternative for portable glucometers, since it uses light to probe samples. Changes in the object of interest can alter the intensity of light returning from the sample and, through it, one can estimate the sample's attenuation coefficient (μt) of light. In this work, we aimed to explore the behavior of μt of mouse’s blood under increasing glucose concentrations. Different samples were prepared in four glucose concentrations using a mixture of heparinized blood, phosphate buffer saline and glucose. Blood glucose concentrations were measured with a blood glucometer, for reference. We have also prepared other samples diluting the blood in isotonic saline solution to check the effect of a higher multiple-scattering component on the ability of the technique to differentiate glucose levels based on μt. The OCT system used was a commercial Spectral Radar OCT with 930 nm central wavelength and spectral bandwidth (FWHM) of 100 nm. The system proved to be sensitive for all blood glucose concentrations tested, with good correlations with the obtained attenuation coefficients. A linear tendency was observed, with an increase in attenuation with higher values of glucose. Statistical difference was observed between all groups (p<0.001). This work opens the possibility towards a non-invasive diagnostic modality using OCT for glycemic control, which eliminates the use of analytes and/or test strips, as in the case with commercially available glucometers.
  • Artigo IPEN-doc 22842
    Optical coherence tomography for blood glucose monitoring in vitro through spatial and temporal approaches
    2016 - PRETTO, LUCAS R. de; YOSHIMURA, TANIA M.; RIBEIRO, MARTHA S.; FREITAS, ANDERSON Z. de
    As diabetes causes millions of deaths worldwide every year, new methods for blood glucose monitoring are in demand. Noninvasive approaches may increase patient adherence to treatment while reducing costs, and optical coherence tomography (OCT) may be a feasible alternative to current invasive diagnostics. This study presents two methods for blood sugar monitoring with OCT in vitro. The first, based on spatial statistics, exploits changes in the light total attenuation coefficient caused by different concentrations of glucose in the sample using a 930-nm commercial OCT system. The second, based on temporal analysis, calculates differences in the decorrelation time of the speckle pattern in the OCT signal due to blood viscosity variations with the addition of glucose with data acquired by a custom built Swept Source 1325-nm OCT system. Samples consisted of heparinized mouse blood, phosphate buffer saline, and glucose. Additionally, further samples were prepared by diluting mouse blood with isotonic saline solution to verify the effect of higher multiple scattering components on the ability of the methods to differentiate glucose levels. Our results suggest a direct relationship between glucose concentration and both decorrelation rate and attenuation coefficient, with our systems being able to detect changes of 65 mg∕dL in glucose concentration.